Location History:
- Madison, NJ (US) (2011)
- Chapel Hill, NC (US) (2013)
Company Filing History:
Years Active: 2011-2013
Title: The Innovative Contributions of Ronald Malone in Immunogenic Formulations
Introduction
Ronald Malone is a notable inventor based in Chapel Hill, NC, recognized for his innovative work in the field of immunogenic compositions. With a focus on enhancing the stability of these compositions, he has garnered two patents that showcase his dedication to advancing immunology and related scientific areas.
Latest Patents
Malone's latest patents revolve around formulations designed to stabilize and inhibit the precipitation of immunogenic compositions. This invention particularly addresses a critical need in the field, improving the stability of complex substances such as polysaccharide-protein conjugates and various protein immunogens. The formulations developed by Malone aim to prevent particulate formation, including aggregation and precipitation, during processes that involve the development, formulation, manufacture, and storage of immunogenic compositions. These formulations are applicable in various container means like fermentors, bioreactors, and vials, ensuring that the integrity of the immunogenic materials is maintained.
Career Highlights
Ronald Malone’s work is carried out at Wyeth, a company renowned for its contributions to the pharmaceutical and biotechnological sectors. His expertise in immunogenic stability plays a crucial role in developing new vaccines and therapeutic solutions that address global health challenges.
Collaborations
Malone's efforts in innovation are often supported by collaborative work with colleagues such as Lakshmi Khandke and Hanyoung Han. Together, they contribute to the ongoing advancements in immunogenic formulations, leveraging their collective expertise to push the boundaries of current scientific knowledge.
Conclusion
In conclusion, Ronald Malone stands out as a pioneering inventor in the realm of immunogenic compositions. His latest patents reflect a commitment to addressing significant challenges in the field, enhancing the stability and efficacy of immunogenic formulations. As he continues his work at Wyeth, the advancements resulting from his innovations are sure to have a lasting impact on immunology and public health.